The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 17, Issue 1, Pages 74-9
Publisher
Future Medicine Ltd
Online
2015-12-15
DOI
10.2217/pgs.15.152
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Positive association between vascular endothelial growth factor (VEGF) -2578 C/A variant and prostate cancer
- (2017) M.L. Martinez-Fierro et al. Cancer Biomarkers
- Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival
- (2015) Oncotarget
- Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression
- (2015) Maura Calvani et al. Oncotarget
- Chronic stress accelerates pancreatic cancer growth and invasion: A critical role for beta-adrenergic signaling in the pancreatic microenvironment
- (2014) Corina Kim-Fuchs et al. BRAIN BEHAVIOR AND IMMUNITY
- Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study
- (2014) C. McCourt et al. BRITISH JOURNAL OF DERMATOLOGY
- Stage-specific associations between beta blocker use and prognosis after colorectal cancer
- (2014) Lina Jansen et al. CANCER
- The association between hypoxia-inducible factor-1 α gene G1790A polymorphism and cancer risk: a meta-analysis of 28 case–control studies
- (2014) Yuqiao Zhou et al. Cancer Cell International
- Beta-blocker usage and prostate cancer survival: A nested case–control study in the UK Clinical Practice Research Datalink cohort
- (2014) Chris R. Cardwell et al. Cancer Epidemiology
- Novel regulatory program for norepinephrine-induced epithelial-mesenchymal transition in gastric adenocarcinoma cell lines
- (2014) Tao Shan et al. CANCER SCIENCE
- VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE-1 study
- (2014) Mario Scartozzi et al. INTERNATIONAL JOURNAL OF CANCER
- Beta-blocker usage and breast cancer survival: a nested case-control study within a UK Clinical Practice Research Datalink cohort
- (2014) Chris R Cardwell et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Vascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancer
- (2014) José Augusto Rinck-Junior et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Association of adrenergic receptor gene polymorphisms in gallbladder cancer susceptibility in a North Indian population
- (2014) Rajani Rai et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Perioperative beta-blocker use and survival in lung cancer patients
- (2014) Juan P. Cata et al. JOURNAL OF CLINICAL ANESTHESIA
- Monoamine oxidase A suppresses hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling
- (2014) Jun Li et al. JOURNAL OF HEPATOLOGY
- Propranolol Inhibits Glucose Metabolism and 18F-FDG Uptake of Breast Cancer Through Posttranscriptional Downregulation of Hexokinase-2
- (2014) F. Kang et al. JOURNAL OF NUCLEAR MEDICINE
- Matrix metalloproteinase-8 promoter gene polymorphisms in Mexican women with ovarian cancer
- (2014) Fabian Arechavaleta-Velasco et al. MEDICAL ONCOLOGY
- Indacaterol Inhibits Tumor Cell Invasiveness and MMP-9 Expression by Suppressing IKK/NF-κB Activation
- (2014) Su Ui Lee et al. MOLECULES AND CELLS
- beta-Adrenoreceptor antagonists reduce cancer cell proliferation, invasion, and migration
- (2014) Özlem Darcansoy İşeri et al. PHARMACEUTICAL BIOLOGY
- Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy
- (2014) T. Langsenlehner et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in Punjabi population from North West India
- (2014) Ruhi Kapahi et al. TUMOR BIOLOGY
- Hypoxia-inducible factor-1α (HIF-1α) C1772T polymorphism significantly contributes to the risk of malignancy from a meta-analysis
- (2014) Gang Wu et al. TUMOR BIOLOGY
- Vascular endothelial growth factor +936C/T polymorphism and breast cancer risk: a meta-analysis of 13 case–control studies
- (2014) Yulan Yan et al. TUMOR BIOLOGY
- -Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort
- (2013) B. M. Hicks et al. ANNALS OF ONCOLOGY
- Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy
- (2013) H. M. Wang et al. ANNALS OF ONCOLOGY
- Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study
- (2013) Sigrun A Johannesdottir et al. BMC CANCER
- Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women
- (2013) Edoardo Botteri et al. BREAST CANCER RESEARCH AND TREATMENT
- Central and peripheral nervous systems: master controllers in cancer metastasis
- (2013) Ming Shi et al. CANCER AND METASTASIS REVIEWS
- The functional −94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer
- (2013) Mohd Shafi’i Mohd Suzairi et al. Cancer Epidemiology
- Associations between Single-Nucleotide Polymorphisms in the PI3K-PTEN-AKT-mTOR Pathway and Increased Risk of Brain Metastasis in Patients with Non-Small Cell Lung Cancer
- (2013) Q. Li et al. CLINICAL CANCER RESEARCH
- β2-AR-HIF-1α: A Novel Regulatory Axis for Stress-Induced Pancreatic Tumor Growth and Angiogenesis
- (2013) T. Shan et al. CURRENT MOLECULAR MEDICINE
- β-Blocker use and all-cause mortality of melanoma patients: Results from a population-based Dutch cohort study
- (2013) E. Livingstone et al. EUROPEAN JOURNAL OF CANCER
- The HIF1A functional genetic polymorphism at locus +1772 associates with progression to metastatic prostate cancer and refractoriness to hormonal castration
- (2013) Avelino Fraga et al. EUROPEAN JOURNAL OF CANCER
- Association Between Use of β-Blockers and Prostate Cancer–Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease
- (2013) Helene Hartvedt Grytli et al. EUROPEAN UROLOGY
- Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: A meta-analysis
- (2013) Chaoliang Hu et al. GENE
- The RTK/ERK pathway is associated with prostate cancer risk on the SNP level: A pooled analysis of 41 sets of data from case–control studies
- (2013) Yang Chen et al. GENE
- Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer—a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG
- (2013) Florian Heitz et al. GYNECOLOGIC ONCOLOGY
- Genetic Polymorphisms of Matrix Metalloproteinases and Clinical Outcomes in Colorectal Cancer Patients
- (2013) Wen-Chien Ting et al. International Journal of Medical Sciences
- Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis
- (2013) Xiaoying Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study
- (2013) Gitte Vrelits Sørensen et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization
- (2013) Massimo Dal Monte et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines
- (2013) Silvia Moretti et al. LABORATORY INVESTIGATION
- Meta-Analysis of MMP2, MMP3, and MMP9 Promoter Polymorphisms and Head and Neck Cancer Risk
- (2013) Caiyun Zhang et al. PLoS One
- Functional Promoter -94 ins/del ATTG Polymorphism in NFKB1 Gene Is Associated with Bladder Cancer Risk in a Chinese Population
- (2013) Pengchao Li et al. PLoS One
- β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy
- (2013) Jing Tang et al. SEMINARS IN CANCER BIOLOGY
- HIF-1α P582S and A588T polymorphisms and digestive system cancer risk—a meta-analysis
- (2013) Xi Yang et al. TUMOR BIOLOGY
- Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population
- (2013) Zhen Wang et al. TUMOR BIOLOGY
- Association of single nucleotide polymorphisms of β2-adrenergic receptor gene with clinicopathological features of pancreatic carcinoma
- (2012) Yu Wenjuan et al. ACTA HISTOCHEMICA
- Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling
- (2012) Donald M. Lamkin et al. BRAIN BEHAVIOR AND IMMUNITY
- Beta blocker use and colorectal cancer risk
- (2012) Lina Jansen et al. CANCER
- EMT in carcinoma progression and dissemination: Facts, unanswered questions, and clinical considerations
- (2012) Jeremy Bastid CANCER AND METASTASIS REVIEWS
- Effect of Long-term Propranolol Treatment on Hepatocellular Carcinoma Incidence in Patients with HCV-Associated Cirrhosis
- (2012) G. Nkontchou et al. Cancer Prevention Research
- STAT3 Polymorphism Can Predict the Response to Interferon-α Therapy in Patients with Metastatic Renal Cell Carcinoma
- (2012) Masatoshi Eto et al. EUROPEAN UROLOGY
- Beta blocker use and ovarian cancer survival: A retrospective cohort study
- (2012) R. Eskander et al. GYNECOLOGIC ONCOLOGY
- Impact of beta blockers on epithelial ovarian cancer survival
- (2012) Elena S. Diaz et al. GYNECOLOGIC ONCOLOGY
- Signal transducer and activator of transcription 3 (STAT3) gene polymorphisms are associated with treatment outcomes in acute myeloid leukemia
- (2012) Y. ZHONG et al. International Journal of Laboratory Hematology
- Association of growth factors, HIF-1 and NF-κB expression with proteasomes in endometrial cancer
- (2012) Ludmila V. Spirina et al. MOLECULAR BIOLOGY REPORTS
- Intercepting neoplastic progression in lung malignancies via the beta adrenergic (β-AR) pathway: Implications for anti-cancer drug targets
- (2012) Hussein A.N. Al-Wadei et al. PHARMACOLOGICAL RESEARCH
- Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy
- (2012) Helene Hartvedt Grytli et al. PROSTATE
- Nuclear factor κB activity correlates with the progression and prognosis of pancreatic cancer in a mouse model
- (2012) Kenei Furukawa et al. SURGERY TODAY
- A Functional Insertion/Deletion Polymorphism (-94 ins/del ATTG) in the Promoter Region of theNFKB1Gene Is Related to the Risk of Renal Cell Carcinoma
- (2012) Hongzhou Cai et al. UROLOGIA INTERNATIONALIS
- Stimulation of Host Bone Marrow Stromal Cells by Sympathetic Nerves Promotes Breast Cancer Bone Metastasis in Mice
- (2012) J. Preston Campbell et al. PLOS BIOLOGY
- Beta-adrenergic blocking drugs in breast cancer: a perspective review
- (2012) Thomas I. Barron et al. Therapeutic Advances in Medical Oncology
- Treatment With β-Blockers and Reduced Disease Progression in Patients With Thick Melanoma
- (2011) Vincenzo De Giorgi et al. ARCHIVES OF INTERNAL MEDICINE
- β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines
- (2011) Kelley S. Madden et al. BREAST CANCER RESEARCH AND TREATMENT
- Involvement of α2- and β2-adrenoceptors on breast cancer cell proliferation and tumour growth regulation
- (2011) C Pérez Piñero et al. BRITISH JOURNAL OF PHARMACOLOGY
- -Blockers and Survival among Danish Patients with Malignant Melanoma: A Population-Based Cohort Study
- (2011) S. Lemeshow et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma
- (2011) L. P. Chung et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Molecular Pathways: Beta-Adrenergic Signaling in Cancer: Figure 1.
- (2011) Steven W. Cole et al. CLINICAL CANCER RESEARCH
- STAT3 gene polymorphisms and susceptibility to non-small cell lung cancer
- (2011) B. Jiang et al. GENETICS AND MOLECULAR RESEARCH
- Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes
- (2011) Li-E Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Beta Blockers and Breast Cancer Mortality: A Population- Based Study
- (2011) Thomas I. Barron et al. JOURNAL OF CLINICAL ONCOLOGY
- Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer
- (2011) Amal Melhem-Bertrandt et al. JOURNAL OF CLINICAL ONCOLOGY
- β2-adrenoceptor blockage induces G1/S phase arrest and apoptosis in pancreatic cancer cells via Ras/Akt/NFκB pathway
- (2011) Dong Zhang et al. Molecular Cancer
- Norepinephrine Promotes the 1-Integrin-Mediated Adhesion of MDA-MB-231 Cells to Vascular Endothelium by the Induction of a GRO Release
- (2011) C. Strell et al. MOLECULAR CANCER RESEARCH
- The cAMP/PKA Pathway Rapidly Activates SIRT1 to Promote Fatty Acid Oxidation Independently of Changes in NAD+
- (2011) Zachary Gerhart-Hines et al. MOLECULAR CELL
- Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients
- (2010) Susan K. Lutgendorf et al. BRAIN BEHAVIOR AND IMMUNITY
- The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells
- (2010) Ming Shi et al. BREAST CANCER RESEARCH AND TREATMENT
- β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NF-κB and AP-1
- (2010) Dong Zhang et al. CANCER BIOLOGY & THERAPY
- The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer
- (2010) E. K. Sloan et al. CANCER RESEARCH
- Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients
- (2010) M. Chen et al. CARCINOGENESIS
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Promoter Polymorphisms in the β-2 Adrenergic Receptor Are Associated With Drug-Induced Gene Expression Changes and Response in Acute Lymphoblastic Leukemia
- (2010) N Pottier et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon
- (2010) S. Kreil et al. HAEMATOLOGICA
- Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism
- (2010) Soon Young Park et al. INTERNATIONAL JOURNAL OF CANCER
- Stress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis
- (2010) Mian M. K. Shahzad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis
- (2010) Anil K. Sood et al. JOURNAL OF CLINICAL INVESTIGATION
- PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy
- (2010) Xia Pu et al. LUNG CANCER
- Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk
- (2009) Meng Chen et al. CARCINOGENESIS
- HIF-1: upstream and downstream of cancer metabolism
- (2009) Gregg L Semenza CURRENT OPINION IN GENETICS & DEVELOPMENT
- Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Are Associated With Clinical Outcomes in Esophageal Cancer Patients Treated With Chemoradiotherapy
- (2009) Michelle A.T. Hildebrandt et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients
- (2009) Su-Shun Lo et al. SURGERY
- Depression, social support, and beta-adrenergic transcription control in human ovarian cancer
- (2008) Susan K. Lutgendorf et al. BRAIN BEHAVIOR AND IMMUNITY
- Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression
- (2008) Eric V. Yang et al. BRAIN BEHAVIOR AND IMMUNITY
- Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via β-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway
- (2008) Xuan Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Propranolol for Severe Hemangiomas of Infancy
- (2008) Christine Léauté-Labrèze et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce cyclooxygenase-2 activity in human gastric cancer cells: Involvement of nicotinic acetylcholine receptor (nAChR) and β-adrenergic receptor signaling pathways
- (2008) Vivian Yvonne Shin et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More